1. BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors

    BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors

    JERUSALEM, Aug. 14, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer, announced today the appointment of Ms. Ruti Alon to its Board of Directors. Frank Haluska, M.D, Ph.D., BioCanCell’s President and Chief Executive Officer, commented, “We are extremely pleased to welcome Ruti to BioCanCell’s Board of Directors. Ruti’s background and experience are an excellent fit as we prepare to launch two pivotal clinical trials of our lead investigational agent, BC-819, either of which may lead to registration in early ...

    Read Full Article
  1. Categories

    1. News:

      News, Placeholder
  2. Quotes

    1. I am truly excited to have the opportunity to join BioCancell's Board of Directors.  BC-819 has the potential to be the first of its kind DNA-directed cancer therapy. I look forward to being part of BioCanCell as it is targeting this serious unmet medical need.
  3. Authors